Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 9 recruiting now later-stage tilt small index

Persistent Atrial Fibrillation: later-stage trial registry

9 of 16 indexed Persistent Atrial Fibrillation trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #1,060 of 28,707 conditions by registered trial count.

16 US clinical trials · 9 currently recruiting · #1,060 of 28,707 conditions by registered trial count

Persistent Atrial Fibrillation: 16 US clinical trials tracked, 9 recruiting.

Persistent Atrial Fibrillation is the subject of 16 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Vivek Reddy, running 3 of these trials.

Enrollment posture brief

Registry condition persistent-atrial-fibrillation

OPEN 9 | RECR 56% | LATE 1 | EARLY 0 | RANK #1060 | SPON 3

Nearest open-share peer: Refractory Acute Myeloid Leukemia (56% recruiting · 64 trials)

Adolescent62.5%Alcohol Intoxication56.3%Persistent Atrial Fibril (th…56%AL Amyloidosis43.8%Allergy18.8%
Open-enrollment share among volume-matched conditions near Persistent Atrial Fibrillation

Persistent Atrial Fibrillation lists 9 open slots (56% of 16 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Persistent Atrial Fibrillation on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Persistent Atrial Fibrillation is recruiting above its size-band peers.

    9 of 16 indexed trials (56.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Persistent Atrial Fibrillation research.

    Vivek Reddy accounts for 3 of 16 trials (18.8%). 12 distinct sponsors appear on at least one study for this condition label.

  3. Typical Persistent Atrial Fibrillation enrolment sits around 250 participants.

    Median target enrolment is 250 among the 16 trials that report a genuine target (sentinel values excluded). 2 of those (12.5%) plan for fewer than 100 participants.

  4. Persistent Atrial Fibrillation research is mostly interventional.

    12 interventional and 4 observational studies make up this index (75% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Open and recent trials

16 total, page 1 of 1

RECRUITING 15,000 participants

Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation

Heart Rhythm Clinical and Research Solutions

NCT04088071

RECRUITING NA 407 participants

Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System

Boston Scientific Corporation

NCT06735534

RECRUITING Phase 4 275 participants

Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias

Vivek Reddy

NCT06765356

RECRUITING NA 250 participants

ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients

Vivek Reddy

NCT05988411

RECRUITING NA 245 participants

Endocardial Mapping With the CoreMap EP Mapping System

CoreMap

NCT06529978

RECRUITING 200 participants

SPHERE Per-AF Post-Approval Study

Medtronic Cardiac Ablation Solutions

NCT06858306

RECRUITING 200 participants

Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System

Kansas City Heart Rhythm Research Foundation

NCT05826665

RECRUITING NA 160 participants

Medtronic Terminate AF Study

Medtronic Cardiac Surgery

NCT03546374

RECRUITING NA 60 participants

ARIADNE Clinical Trial

Stavros E Mountantonakis

NCT06747091

ACTIVE NOT RECRUITING NA 549 participants

Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation

Kardium

NCT05462145

ACTIVE NOT RECRUITING NA 484 participants

Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation

Boston Scientific Corporation

NCT06096337

ACTIVE NOT RECRUITING 400 participants

STOP Persistent AF PAS

Medtronic Cardiac Ablation Solutions

NCT05005949

ACTIVE NOT RECRUITING NA 150 participants

AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment

AtriCure

NCT03732794

COMPLETED NA 350 participants

Randomized Evaluation of Atrial Fibrillation Treatment With Focal Impulse and Rotor Modulation Guided Procedures

Abbott Medical Devices

NCT02274857

COMPLETED NA 110 participants

Comparison of Pulmonary Vein Ablation With or Without Left Atrial Posterior Wall Ablation for Persistent AF (PIVoTAL)

Arash Aryana, MD

NCT03057548

COMPLETED NA 65 participants

RADAR Clinical Trial

Vivek Reddy

NCT03263702

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Persistent Atrial Fibrillation records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Cryo or RF Ablation of Pulmonary Veins plus Ablation of the PLAW Procedure
1 trials
Cryo or Radiofrequency (RF) Ablation only of Pulmonary Veins Procedure
1 trials
FIRM-Guided Procedure and PVI Procedure
1 trials
Standard PVI Ablation Procedure
1 trials
Computational Mapping Algorithm Device
1 trials
Globe Pulsed Field System Device
1 trials
Arctic Front™ Cardiac Cryoablation Catheter System Device
1 trials
AtriCure CryoICE & AtriClip LAA Exclusion Device
1 trials

US sites by state

Facility locations filed on Persistent Atrial Fibrillation trials. A trial with sites in several states counts in each.

New York 9 trials
Florida 9 trials
California 9 trials
Arkansas 7 trials
Ohio 6 trials
Pennsylvania 5 trials
Michigan 5 trials
Maryland 5 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Persistent Atrial Fibrillation page

16 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 9 Persistent Atrial Fibrillation trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Vivek Reddy sponsors the most Persistent Atrial Fibrillation trials on record, review their full trial history before evaluating a specific study. See Vivek Reddy's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Persistent Atrial Fibrillation condition card totals 16 registered trials; most-linked intervention Cryo or RF Ablation of Pulmonary Veins plus Ablation of the PLAW; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.